HomeCompareJAVTX vs JNJ

JAVTX vs JNJ: Dividend Comparison 2026

JAVTX yields 6.04% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JAVTX wins by $9.8K in total portfolio value
10 years
JAVTX
JAVTX
● Live price
6.04%
Share price
$78.33
Annual div
$4.73
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$29.8K
Annual income
$887.89
Full JAVTX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — JAVTX vs JNJ

📍 JAVTX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodJAVTXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, JAVTX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
JAVTX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

JAVTX
Annual income on $10K today (after 15% tax)
$513.53/yr
After 10yr DRIP, annual income (after tax)
$754.71/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JAVTX beats the other by $51.09/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of JAVTX + JNJ for your $10,000?

JAVTX: 50%JNJ: 50%
100% JNJ50/50100% JAVTX
Portfolio after 10yr
$24.9K
Annual income
$857.83/yr
Blended yield
3.44%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

JAVTX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

JAVTX buys
0
JNJ buys
0
No recent congressional trades found for JAVTX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricJAVTXJNJ
Forward yield6.04%3.36%
Annual dividend / share$4.73$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$29.8K$20.0K
Annual income after 10y$887.89$827.78
Total dividends collected$7.5K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: JAVTX vs JNJ ($10,000, DRIP)

YearJAVTX PortfolioJAVTX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,304$604.15$10,676$355.77+$628.00JAVTX
2$12,734$638.27$11,407$389.39+$1.3KJAVTX
3$14,297$671.95$12,198$426.53+$2.1KJAVTX
4$16,003$705.09$13,056$467.62+$2.9KJAVTX
5$17,861$737.58$13,987$513.12+$3.9KJAVTX
6$19,880$769.36$14,998$563.56+$4.9KJAVTX
7$22,072$800.33$16,098$619.52+$6.0KJAVTX
8$24,448$830.44$17,295$681.69+$7.2KJAVTX
9$27,019$859.64$18,599$750.82+$8.4KJAVTX
10$29,798$887.89$20,022$827.78+$9.8KJAVTX

JAVTX vs JNJ: Complete Analysis 2026

JAVTXStock

The fund pursues its investment objective by investing at least 50% of its equity assets in small-sized companies. It may also invest in larger companies with strong growth potential. Small-sized companies are defined by the portfolio manager as those companies whose market capitalization falls within the range of companies in the Russell 2000® Growth Index at the time of initial purchase. The fund may also invest in foreign securities, which may include investments in emerging markets.

Full JAVTX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this JAVTX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

JAVTX vs SCHDJAVTX vs JEPIJAVTX vs OJAVTX vs KOJAVTX vs MAINJAVTX vs ABBVJAVTX vs MRKJAVTX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.